IntronBio's Patent on Inhibiting the Growth of Enterobacter cloacae and Others
[Asia Economy Reporter Oh Ju-yeon] Intronbio announced on the 22nd that it has acquired a patent for the Enterobacter aerogenes bacteriophage Ent-AEP-1 and its use in inhibiting the proliferation of Enterobacter aerogenes and Enterobacter cloacae strains. The company stated, "We plan to utilize this patented technology to develop treatments for infections caused by gram-negative bacteria, such as CRE infections."
Hot Picks Today
As Samsung Falters, Chinese DRAM Surges: CXMT Returns to Profit in Just One Year
- "Most Americans Didn't Want This"... Americans Lose 60 Trillion Won to Soaring Fuel Costs
- Iran Delivers New Ceasefire Proposal to U.S.; U.S. Says "Not Sufficient to Conclude Negotiations"
- Samsung Union Member Sparks Controversy With Telegram Post: "Let's Push KOSPI Down to 5,000"
- "Why Make Things Like This?" Foreign Media Highlights Bizarre Phenomenon Spreading in Korea
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
